|
Orthologous residues
|
|
CBP (human): S302‑p, CBP (mouse): S301‑p, CBP (rat): S301‑p
|
|
Characterization
|
|
Methods used to characterize site in vivo:
mutation of modification site, phospho-antibody, western blotting
|
|
Relevant cell lines - cell types - tissues:
'neuron, hippocampal'-brain
|
|
Cellular systems studied:
primary cells
|
|
Species studied:
rat
|
|
Enzymes shown to modify site in vitro:
|
|
|
|
Upstream Regulation
|
|
Potential in vivo enzymes for site:
|
|
Type
|
Enzyme
|
Evidence
|
Notes
|
|
KINASE
|
CaMK4 (human)
|
genetic transfer of constitutively active upstream enzyme, pharmacological inhibitor of upstream enzyme, genetic transfer of dominant-negative enzyme
|
|
|
|
Treatments, proteins and their effect on site modification:
|
|
Treatments
|
Referenced Treatments
|
Manipulated Protein
|
Referenced Protein
|
Effect
|
Notes
|
|
NMDA
|
|
|
|
increase
|
|
|
KN-93
|
NMDA
|
|
|
inhibit treatment-induced increase
|
|
|
|
Downstream Regulation
|
|
Effect of modification (process):
transcription, altered
|